SCHEMBL6432302

SCHEMBL6432302

Cc1nccc2[nH]c(=O)c(-c3noc(C4CC4)n3)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.59
HSD17B10 Q99714 8/20 0.59
ALDH1A1 P00352 6/20 0.48
HPGD P15428 6/20 0.48
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 2/20 0.42
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886299 0.73 HSD17B10 (0.54) KDM4EHSD17B10ALDH1A1HPGDPDE3B
SCHEMBL1352172 0.70 MEN1 (0.55) KDM4EHSD17B10ALDH1A1HPGDPDE3B
SCHEMBL4887564 0.70 PDE3B (0.45) KDM4EHSD17B10ALDH1A1HPGDPDE3B
SCHEMBL4891258 0.70 KDM4E (0.42) KDM4EHSD17B10ALDH1A1HPGDMAPT
SCHEMBL4888765 0.69 KDM4E (0.52) KDM4EHSD17B10ALDH1A1HPGDMAPT
SCHEMBL18190702 0.69 KDM4E (0.49) KDM4EHSD17B10ALDH1A1HPGDRAB9A
SCHEMBL4890983 0.68 PDE3B (0.54) KDM4EHSD17B10ALDH1A1HPGDPDE3B
SCHEMBL31672793 0.67 KDM4E (0.36) KDM4EALDH1A1PDE3BPDE3ASMN1; SMN2
SCHEMBL10809624 0.66 PDE3B (0.60) KDM4EALDH1A1PDE3BPDE3ASMN1; SMN2
SCHEMBL10812608 0.66 PDE3B (0.60) KDM4EHSD17B10ALDH1A1HPGDPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010699-B1 5-SUBSTITUTED-3-OXADIAZOLYL-1,6-NAPHTHYRIDIN-2(1H)-ONE DERIVATIVES DAINIPPON PHARMACEUTICAL CO (JP) 2005-06-15 EP disclosed
US-6277993-B1 USEFUL AS A BENZODIAZEPINE INVERSE AGONIST, FOR EXAMPLE, AS PSYCHOANALEPTIC DRUG OR DRUG FOR TREATMENT OF DYSMNESIA IN SENILE DEMENTIA OR ALZHEIMER'S DISEASE DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2001-08-21 US disclosed
US-6172079-B1 BENZODIAZEPINE INVERSE AGONISTS; ALZHEIMER*S DISEASE; ANXIOLYTIC AGENTS, SEDATIVES, MUSCLE RELAXANTS, ANTIEPILEPTIC AGENTS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2001-01-09 US disclosed
EP-1010699-A1 5-SUBSTITUTED-3-OXADIAZOLYL-1,6-NAPHTHYRIDIN-2(1H)-ONE DERIVATIVES DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2000-06-21 EP disclosed